Canada Just Got Played": How Mexico Stabbed Canada In The

New Post Public Reply Private Reply Replies (2) Message Board
Lmcat
103
Canada Just Got Played": How Mexico Stabbed Canada In The Back
08/28/2018

In what was the biggest economic news of the day, Donald Trump concluded bilateral trade negotiations with Mexico, a deal which he called the US-Mexico Trade Agreement and which will replace the trilateral NAFTA which has - for now at least - been scrapped until Canada also comes to the negotiating table and hammers out an agreement with the US (read: concedes), from a position of weakness and virtually no negotiating capital.

There were some odd twists in the announced deal, for example the agreement on the "sunset clause", which as some pointed out is strange as it is a "trilateral matter" - i.e., one which would involve Canada - and it was unclear how it squares with the U.S.Mexico pledge that their talks were purely on bilateral issues.

Confirming that Trump was engaging in some good old "divide and conquer", was the announcement from a White House official that, if Canada doesn't agree to a renegotiated NAFTA, it will go ahead with a two-way deal with Mexico, although another official claimed that splitting up the negotiations is "standard practice and not about squeezing Canada."

That may not have been exactly true because even though Mexico’s foreign minister Luis Videgaray said it’s necessary for Canada to be part of the deal, he then said that if a trilateral Nafta deal with Canada is impossible, a bilateral agreement between the U.S. and Mexico would also be acceptable.

At this point the alarm bells went off, "it looks like the U.S. and Mexico went far beyond bilateral issues and agreed to a pile of trilateral stuff without Canada." He also noted that while it was unclear whether any of the negotiated terms were okay with Canada, "it puts enormous pressure on Ottawa to agree or hold up the deal."

Furthermore, Morrow points out that unless Canada already agreed to these trilateral issues — sunset compromise, IP etc. — via its back-channel with Mexico, "the U.S. and Mexico have just massively cranked up the pressure."

In other words, Mexico just stabbed Canada in the back in order to get a deal with the US on preferential terms to Canada, just as Trump desired, and in vivid demonstration of applied game theory in practice.

Adding pressure on Canada, Morrow quoted Videgaray who said that Mexico’s deal with the U.S. is a "comprehensive" agreement, and warned that if Canada doesn’t reach a deal this week, it will be much harder for Ottawa to negotiate any changes to what’s already been agreed.

Which is a not very subtle ultimatum to Canada to get on board or lose any leverage it may have; and although Videgaray tried to wash his hands and said that Mexico can’t control state of relationship between U.S. and Canada, the message was received loud and clear.

Here Morrow makes two key observations: "because of U.S. trade law, it would be very difficult for the U.S. and Mexico to do a bilateral without Canada at this point," but confirming the dagger in the back interpretation, "it looks like Mexico is helping Trump turn the pressure up on Canada. They agreed a nearly-complete deal without Canada at the table" something which Videgaray confirmed saying today is a good day for Mexico, U.S. relations.

Because of U.S. trade law, it would be very difficult for the U.S. and Mexico to do a bilateral without Canada at this point. But it looks like Mexico is helping Trump turn the pressure up on Canada. They agreed a nearly-complete deal without Canada at the table
— Adrian Morrow (@AdrianMorrow) August 27, 2018

Turns out that the art of the deal does work on occasion.

Meanwhile, although it is possible that there’s a secret Canada-Mexico understanding here, if there isn't, "it’s hard to see this as anything other than Canada getting played", Morrow wryly observes, and adds that "Mexico is blowing up the Canadian spin that Mexico and the U.S. weren’t agreeing anything Canada needed to be at the table for."

It’s possible there’s a secret Canada-Mexico understanding here. But if not, it’s hard to see this as anything other than Canada getting played. Mexico is blowing up the Canadian spin that Mexico and the U.S. weren’t agreeing anything Canada needed to be at the table for
— Adrian Morrow (@AdrianMorrow) August 27, 2018

As a final point, much of what was agreed today was "style over substance", as the substance of the deal (mostly) doesn't look that bad for Canada: Mexico gave up more with its concessions on autos. But as the Canadian journalist cautions, "this is definitely not how Canada would have chosen to negotiate, cut out of talks and now pressured from two sides to agree a deal in a week."

So what does being stabbed in the back by Mexico mean for Canada? Morrow concludes that Ottawa will "probably spend all of its negotiating capital this week trying to keep Chapter 19, which Mexico has apparently agreed to scrap, nevermind trying to defend on any of the other things it won't like in the U.S.-Mexico deal."

Said otherwise, Mexico made some concessions but kept its US market exposure, even as Canada is now cornered and has virtually no leverage or political capital left.

The winner from today's deal?

https://www.zerohedge.com/sites/default/files...k=-7ZcK70o

https://www.zerohedge.com/news/2018-08-27/how...anada-back
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Morgan Stanley Projects Strong Upswing for Consumer Finance

Updated Category News Views 259

Morgan Stanley's Positive Outlook for Consumer Finance Stocks Morgan Stanley has recently made an uplifting adjustment to its outlook on consumer finance stocks, now branding them as "attractive." This decision stems from robust fundamentals and an improved regulatory environment, setting an optimistic tone for the sector. Key Drivers of Change The primary catalysts...

Continue Reading
Significant Board Restructuring at O2Gold Inc. Announced

Updated Category News Views 71

O2Gold Board Announces Key Changes O2Gold Inc. (NEX: OTGO.H), a dedicated mineral exploration company, has recently undergone a significant change in its board structure. The company has announced that Roger Lemaitre has resigned from his position as a director. This decision marks a pivotal moment for O2Gold as it continues to navigate its exploration initiatives....

Continue Reading
Taylor Morrison Launches Holiday Initiative to Support Homeowners

Updated Category News Views 265

Help for Homeowners During the Holidays In a time when financial strain can be prominent, especially during the holidays, Taylor Morrison (NYSE: TMHC) is stepping up to lend a hand. The renowned homebuilder has introduced an initiative designed to support homeowners facing the threat of foreclosure. With the holiday season often heightening financial challenges, the...

Continue Reading
flatexDEGIRO Moves Ahead After Ending BaFin Oversight

Updated Category News Views 188

flatexDEGIRO Ends Special Commissioner Mandate FRANKFURT - flatexDEGIRO AG, a prominent German financial services provider, has officially announced the conclusion of the special commissioner mandate set by the Federal Financial Supervisory Authority (BaFin). This change will take effect on a specified date in the future. The company has made significant strides in...

Continue Reading
Investigating Alvotech's Regulatory Challenges After Stock Drop

Updated Category News Views 125

Alvotech Faces Scrutiny over Manufacturing Issues National shareholder rights firm Hagens Berman is currently analyzing Alvotech (NASDAQ: ALVO) regarding potential misrepresentations in their disclosures tied to manufacturing operations and the regulatory status of their primary biosimilar candidate, AVT05. Impact of FDA's Complete Response Letter The investigation stems...

Continue Reading